Title
Cytosolic pH regulates proliferation and tumour growth by promoting expression of cyclin D1
Date Issued
01 November 2020
Access level
open access
Resource Type
journal article
Author(s)
Koch L.M.
Birkeland E.S.
Battaglioni S.
Helle X.
Meerang M.
Hiltbrunner S.
Peter M.
Curioni-Fontecedro A.
Opitz I.
Dechant R.
Publisher(s)
Nature Research
Abstract
Enhanced growth and proliferation of cancer cells are accompanied by profound changes in cellular metabolism. These metabolic changes are also common under physiological conditions, and include increased glucose fermentation accompanied by elevated cytosolic pH (pHc)1,2. However, how these changes contribute to enhanced cell growth and proliferation is unclear. Here, we show that elevated pHc specifically orchestrates an E2F-dependent transcriptional programme to drive cell proliferation by promoting cyclin D1 expression. pHc-dependent transcription of cyclin D1 requires the transcription factors CREB1, ATF1 and ETS1, and the histone acetyltransferases p300 and CBP. Biochemical characterization revealed that the CREB1–p300/CBP interaction acts as a pH sensor and coincidence detector, integrating different mitotic signals to regulate cyclin D1 transcription. We also show that elevated pHc contributes to increased cyclin D1 expression in malignant pleural mesotheliomas (MPMs), and renders these cells hypersensitive to pharmacological reduction of pHc. Taken together, these data demonstrate that elevated pHc is a critical cellular signal regulating G1 progression, and provide a mechanism linking elevated pHc to oncogenic activation of cyclin D1 in MPMs, and possibly other cyclin D1~dependent tumours. Thus, an increase of pHc may represent a functionally important, early event in the aetiology of cancer that is amenable to therapeutic intervention.
Start page
1212
End page
1222
Volume
2
Issue
11
Language
English
OCDE Knowledge area
Oncología
Biotecnología relacionada con la salud
Scopus EID
2-s2.0-85092708861
PubMed ID
Source
Nature Metabolism
ISSN of the container
25225812
Sponsor(s)
ETH Zürich Foundation
We thank P. Kimmig, S. Gilberto, K. F. Marquart, W. Kovacs, M. Stoffel, A. Smith and members of the Peter, Curioni and Opitz laboratories for helpful discussions and comments on the manuscript; B. Vrugt, Ch. Mittmann and M. Glönkler, Department of Pathology and Molecular Pathology, University Hospital Zurich, for help with establishment of NHE1 and cyclin D1 IHC, the Functional Genomics Center Zürich (FGCZ) for support with RNA-seq and metabolomics and M. Okoniewski (Scientific IT Services ETH) for help with bioinformatic analyses. Work in the Dechant, Peter, Curioni and Opitz laboratories is funded by the SNF, ETHZ (ETH research grant 28 17-2 to RD) and the Medical University of Zurich.
Sources of information:
Directorio de Producción Científica
Scopus